Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

This is not your grandfather’s Lego. But perhaps your father still plays with the delightful little bricks. Lego is not ...

Denmark has achieved one of the goals of the Green Tripartite Agreement by designating 75,000 hectares of untouched forest. This is part of the broader plan to enhance biodiversity and allow nature to ...

In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

Denmark is spending nearly 15 billion kroner to strengthen its defense in the Arctic and North Atlantic. This spending is part of a new agreement with the Faroese government and Greenland’s ...

I’m not going to report record revenue, but it was nonetheless a robust year," CEO Bernard Arnault said during the earnings ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

The Kokomo woman was pre-diabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

Meanwhile, Wisconsin Supreme Court race could determine the future of abortion in the state; Minnesota will implement insulin price cap; Denver hospital opens its free naloxone vending machine; and ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, ...

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...